Literature DB >> 2110696

Transferrin receptor expression in tumours of the human nervous system: relation to tumour type, grading and tumour growth fraction.

R Prior1, G Reifenberger, W Wechsler.   

Abstract

The expression of transferrin receptor (Tr) was investigated by means of immunohistochemistry in 101 tumours of the human central and peripheral nervous system. The results were compared with the proliferative activity of the tumours, determined by immunostaining for the proliferation-associated antigen Ki-67. In addition to immunostaining of normal and proliferated blood vessel endothelium and of a fraction of tumour infiltrating lymphocytes, we observed staining for Tr in a variable fraction of neoplastic cells of all histological tumour types. Immunoreactivity in the majority of tumour cells was found only in anaplastic tumours such as glioblastomas. Furthermore, a positive correlation between Tr expression and the Ki-67 growth fraction was established for gliomas. Non-glial tumours strongly expressing Tr included one metastatic rhabdomyosarcoma, one intracerebral malignant lymphoma, two of four plasmocytomas and seven of nine metastatic carcinomas. Our results indicate that immunohistochemistry for Tr and Ki-67 can provide additional information about the biological behaviour of nervous system tumours, thus complementing conventional histopathological criteria for anaplasia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110696     DOI: 10.1007/bf01600299

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  33 in total

1.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

2.  Transferrin receptors: structure and function.

Authors:  I S Trowbridge; R A Newman; D L Domingo; C Sauvage
Journal:  Biochem Pharmacol       Date:  1984-03-15       Impact factor: 5.858

3.  Nerve growth factor receptor in tumours of the human nervous system. Immunohistochemical analysis of receptor expression and tumour growth fraction.

Authors:  R Prior; G Reifenberger; W Wechsler
Journal:  Pathol Res Pract       Date:  1989-09       Impact factor: 3.250

4.  Immunophenotype of small cell lung carcinoma. Expression of NKH-1 and transferrin receptor and absence of most myeloid antigens.

Authors:  M I Doria; A G Montag; W A Franklin
Journal:  Cancer       Date:  1988-11-01       Impact factor: 6.860

5.  Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system.

Authors:  G Reifenberger; R Prior; M Deckert; W Wechsler
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

6.  Regulation of transferrin receptor expression in concanavalin A stimulated and Gross virus transformed rat lymphoblasts.

Authors:  T A Hamilton
Journal:  J Cell Physiol       Date:  1982-10       Impact factor: 6.384

7.  Sensitivity of human glioma cells to cytotoxic heteroconjugates.

Authors:  M Colombatti; M Bisconti; L Dell'Arciprete; M A Gerosa; G Tridente
Journal:  Int J Cancer       Date:  1988-09-15       Impact factor: 7.396

8.  Primary structure of human transferrin receptor deduced from the mRNA sequence.

Authors:  C Schneider; M J Owen; D Banville; J G Williams
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

9.  The role of the transferrin receptor in human B lymphocyte activation.

Authors:  L M Neckers; G Yenokida; S P James
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

10.  Transferrin receptor expression in the leukaemias and lymphoproliferative disorders.

Authors:  D Barnett; G A Wilson; A C Lawrence; G A Buckley
Journal:  Clin Lab Haematol       Date:  1987
View more
  23 in total

1.  Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma.

Authors:  Fernanda I Staquicini; Michael G Ozawa; Catherine A Moya; Wouter H P Driessen; E Magda Barbu; Hiroyuki Nishimori; Suren Soghomonyan; Leo G Flores; Xiaowen Liang; Vincenzo Paolillo; Mian M Alauddin; James P Basilion; Frank B Furnari; Oliver Bogler; Frederick F Lang; Kenneth D Aldape; Gregory N Fuller; Magnus Höök; Juri G Gelovani; Richard L Sidman; Webster K Cavenee; Renata Pasqualini; Wadih Arap
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

Review 2.  Convection-Enhanced Delivery.

Authors:  A M Mehta; A M Sonabend; J N Bruce
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

Review 3.  Experimental approaches for the treatment of malignant gliomas.

Authors:  Leopold Arko; Igor Katsyv; Grace E Park; William Patrick Luan; John K Park
Journal:  Pharmacol Ther       Date:  2010-06-08       Impact factor: 12.310

Review 4.  Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma.

Authors:  Aniket S Wadajkar; Jimena G Dancy; David S Hersh; Pavlos Anastasiadis; Nhan L Tran; Graeme F Woodworth; Jeffrey A Winkles; Anthony J Kim
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-11-04

Review 5.  The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

Authors:  Tracy R Daniels; Ezequiel Bernabeu; José A Rodríguez; Shabnum Patel; Maggie Kozman; Diego A Chiappetta; Eggehard Holler; Julia Y Ljubimova; Gustavo Helguera; Manuel L Penichet
Journal:  Biochim Biophys Acta       Date:  2011-08-05

6.  Morphological, immunocytochemical and growth characteristics of three human glioblastomas established in vitro.

Authors:  T Bilzer; D Stavrou; E Dahme; E Keiditsch; K F Bürrig; A P Anzil; W Wechsler
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

7.  Revisiting intra-arterial drug delivery for treating brain diseases or is it "déjà-vu, all over again"?

Authors:  Shailendra Joshi; Jason A Ellis; Charles W Emala
Journal:  J Neuroanaesth Crit Care       Date:  2014-05

8.  In vivo molecular mapping of the tumor microenvironment in an azoxymethane-treated mouse model of colon carcinogenesis.

Authors:  Sarah J Leung; Photini S Rice; Jennifer K Barton
Journal:  Lasers Surg Med       Date:  2014-12-09       Impact factor: 4.025

Review 9.  Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.

Authors:  Stephanie Tortorella; Tom C Karagiannis
Journal:  J Membr Biol       Date:  2014-02-27       Impact factor: 1.843

10.  Brain tumor iron uptake measured with positron emission tomography and 52Fe-citrate.

Authors:  U Roelcke; K L Leenders; K von Ammon; E W Radü; P Vontobel; I Günther; M Psylla
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.